中科創達(300496.SZ):目前滴水 OS、Rubik Pi 以及智能模組計算平台均已完成高通平台對Deepseek的適配工作
格隆匯2月21日丨中科創達(300496.SZ)於投資者互動平台表示,目前,公司的滴水 OS、Rubik Pi 以及智能模組計算平台均已完成高通平台對 Deepseek 的適配工作。公司秉持開放合作的理念,會根據客户的實際需求,靈活選擇是否融合 DeepSeek 方案。對於 DeepSeek 相關模型的適配以及在端側的部署,公司正在與客户進行深入商洽。截至目前尚未形成明確訂單,其對公司未來經營業績的影響還存在一定的不確定性,提醒投資者注意風險,謹慎做出投資決策。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.